Our Products

API Intermediates - Commercial scale

S. No Structure CAS. No Chemical Name End Use Availability
1 811803-05-1 Apatanib (Rivoceranib)
(2018 aproved drug)
API/Oncology/Anticancer agent
R&D Completed
2 NA Methyl-(S)-3-(4-(Bis(2-Hydoxyethyl)
amino)Phenyl-2((Ethoxy carbonyl)yl
Amino)Propanoate
Melphalan Hydrochloride Commercial/MTO
3 169472-17-7 Methyl-(S)-3-(4-Aminophenyl)-2- ((Ethoxy carbonyl)amino) Propanoate Melphalan Hydrochloride Commercial/1 kg ready Stock
4 35202-54-1 4,5-Dimethoxy-1- cyanobenzocyclobutane Ivabradine Commercial/1 kg ready Stock
5 179688-29-0 6,7-bis(2- methoxyethoxy)quinazolin-4-ol Erlotinib Commercial/MTO
6 221615-75-4 KetoSulphone Etoricoxib Commercial/MTO
7 3382-63-6 4-{(4-fluorophenyl)imino)methyl}phenol Ezetimibe Commercial/MTO
8 189028-95-3 (4S)-3-((5R)-5-(4-
fluorophenyl)-5- hydroxypentanoyl)-4-phenyl- 1,3-oxzolidin-2-one
Ezetimibe Commercial/MTO
9 679394-62-8 Alpha Methylamino-M-Hydroxy Acetophenone sulphate Phenylephrine HCl Commercial/MTO
10 66670-11-9 Methyl 4-oxo-1-phenethylpiperidine-3-carboxylate Fentanil
intermediate
Commercial/MTO
11 5294-61-1 N-(2,6-dimethylphenyl)-2- (piperazin-1-yl)acetamide Ranolazine Commercial/MTO
12 330792-70-6 3-amino-5-(4-phenoxyphenyl)- 1H-pyrazole-4-carbonitrile Ibrutinib Commercial/MTO
13 873-74-5 4-Amino Benzonitrile Dabigatran Commercial/MTO
14 42288-26-6 2-((4-Cyanophenyl)amino Acetic acid Dabigatran Commercial/MTO
15 2374-03-0 4-Amino-3-hydroxybenzoic acid Tafamidis Commercial/MTO
16 321-14-2 5-Chloro salicyclic acid Pharmaceutical intermediate Commercial/MTO
17 106-96-7 Propargyl bromide Pharmaceutical intermediate Commercial/MTO
19 57260-71-6 1-Boc Piperazine Pharmaceutical intermediate MTO/Sample provided
20 31166-44-6 Benzyl piperazine-1-Carboxylate Pharmaceutical intermediate Under progress
21 20980-22-7 2-(1-Piperazinyl)pyrimidine Buspirone Intermediate MTO/Sample provided
32 108-98-5 Thiophenol Etoricoxib Raw material Under Progress